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Unique subgingival microbiota 
associated with periodontitis in 
cirrhosis patients
Anders Jensen1, Lea Ladegaard Grønkjær2, Palle Holmstrup3, Hendrik Vilstrup2 & 
Mogens Kilian1
Liver cirrhosis is a severe disease with major impact on the overall health of the patient including poor 
oral health. Lately, there has been increasing focus on oral diseases as cirrhosis-related complications 
due to the potential impact on systemic health and ultimately mortality. Periodontitis is one of the most 
common oral diseases in cirrhosis patients. However, no studies have investigated the composition 
of the subgingival microbiome in patients suffering from periodontitis and liver cirrhosis. We analysed 
the subgingival microbiome in 21 patients with periodontitis and cirrhosis using long-reads Illumina 
sequencing. The subgingival microbiota was dominated by bacteria belonging to the Firmicutes 
phylum and to a lesser extend the Actinobacteria and Bacteroidetes phyla. Bacteria usually considered 
periodontal pathogens, like Porhyromonas ginigivalis, Tannerella forsythia, Treponema denticola, 
generally showed low abundancy. Comparing the microbiota in our patients with that of periodontitis 
patients and healthy controls of three other studies revealed that the periodontitis-associated 
subgingival microbiota in cirrhosis patients is composed of a unique microbiota of bacteria not normally 
associated with periodontitis. We hypothesise that periodontitis in cirrhosis patients is a consequence 
of dysbiosis due to a compromised immune system that renders commensal bacteria pathogenic.
Periodontitis is a bacterially induced inflammatory disease that affects the supporting tissues of teeth, character-
ized by loss of connective tissue and bone with ensuing deepening of the periodontal pockets. Untreated, perio-
dontitis may result in loosening of teeth with discomfort, impaired mastication, pain, and ultimately tooth loss1,2. 
Periodontitis in adults is caused by loss of the natural balance between the oral microbiota and host resistance 
(dysbiosis) due to life style factors, e.g. insufficient oral hygiene and tobacco smoking, combined with genetically 
and disease-associated jeopardization of host defence. Ensuing changes in the relative abundances of members 
of the complex microbiota that accumulate on the teeth toward pro-inflammatory species trigger a host response 
that includes release of inflammatory exudates, which further stimulate changes in the microbiota. In some cases, 
this dysbiosis leads to a situation where a destructive inflammatory response results in degradation of connective 
tissue and periodontal bone3–5. In addition, environmental and genetic factors secondary to these inflammatory 
and destructive events may continue to support a pathogenic microbiota and perpetuate the cycle of events4.
Poor oral health, including oral diseases such as periodontitis, is prevalent in patients with liver cirrhosis6–8, 
which is the final pathway for several liver diseases defined as the histological development of regeneration nod-
ules surrounded by fibrous tissue9. The prevalence of oral diseases is not a trivial problem as it may have systemic 
implications. Thus, studies have assessed the association between periodontitis and several systemic diseases and 
an increasing number of studies have suggested that oral diseases may affect the course of systemic diseases10. 
Thus, our previous cross-sectional studies in patients with cirrhosis indicated an association between oral diseases 
and a higher nutritional risk score, systemic inflammation activation, increased frequency of cirrhosis-related 
complications and even higher mortality in cirrhosis patients suffering from periodontitis11–13. Possible mech-
anisms of the systemic effects include spreading of oral bacteria and bacterial products, either by aspiration 
or through the bloodstream facilitated by periodontal inflammation14. Moreover, a spill over of inflammatory 
cytokines may enter the circulation and induce and perpetuate systemic effects15.
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In recent years, numerous studies have shown that the human microbiome is involved in health and diseases 
in humans and dysbiosis of the human microbiome has been associated with several diseases like obesity, diabe-
tes and neurological disorders16–20. Also, oral diseases like periodontitis have been associated with a dysbiosis of 
the oral microbiome5. Several studies have shown that liver cirrhosis may cause dysbiosis of the gut microbiome 
and changes associated with the severity and outcome of the liver cirrhosis21–24. Some studies have shown that 
the dysbiosis of the gut microbiome in liver cirrhosis patients is mostly caused by increased abundancy of oral 
bacteria compared to healthy controls24–26. Only a few studies, however, have examined the oral microbiome in 
patients with cirrhosis27,28. Bajaj et al.27 found dysbiosis of the salivary microbiome in patients with cirrhosis with 
hepatic encephalopathy, which may be caused by mucosal immune interface changes. However, no studies have 
examined the subgingival plaque microbiome in patients with alcohol-induced liver cirrhosis and periodontitis.
To have a more thorough understanding of the complex role of the oral hygiene and especially periodontitis 
in the outcome of liver cirrhosis patients that we have seen in our companion studies, it is also of great impor-
tance to have a comprehensive mapping of the subgingival microbiome from patients with periodontitis and liver 
cirrhosis.
The aim of the study was therefore to make a comprehensive mapping of the subgingival plaque microbiome 
in liver cirrhosis patients with periodontitis. Our results show that the subgingival microbiota in liver cirrhosis 
patients with periodontitis is unique and that bacteria normally associated with periodontitis are found only in 
very low proportions. We hypothesise that this may be due to an altered immune status in liver cirrhosis patients 
allowing bacteria not normally associated with periodontitis in otherwise healthy patients to induce periodontitis.
Methods
This clinical part of this study was conducted between May and August 2015 at Aarhus University Hospital, 
Denmark. Eligible Patients were consecutively enrolled at the Department of Hepatology and Gastroenterology 
for a program on oral health and oral infections in patients with cirrhosis11,12. The present study focused on the 
oral microbiota.
Eligible patients were adult men (N = 16) and woman (N = 5) with an established diagnosis of cirrhosis 
regardless of aetiology and severity. The diagnosis of cirrhosis was based on medical history, physical examina-
tion, liver biopsy and/or pertinent clinical-biochemical, and ultrasonographic findings.
Oral Examination. At study entry, a standardized oral examination was performed and combined with the 
collection of subgingival plaque from two pathologic periodontal pockets (see below) in two different quadrants. 
Clinical probing depths (PD) of the gingival pockets were measured parallel to the longitudinal axis of the tooth 
from the free gingival margin to the tip of the periodontal probe. Clinical attachment level (CAL) of the gingiva 
was defined as the distance from the cemento-enamel junction (CEJ) to the tip of the periodontal probe. PD 
and CAL were registered at six sites per tooth, measured in mm, and recorded to the nearest mm. All samples 
were taken from sites deeper than 4 mm and up to 6 mm. Bleeding on probing (BOP) was registered if bleeding 
occurred within 15 seconds after probing. Periodontitis was defined and classified as mild, moderate or severe, 
as described by the working group of the Centre for Disease Control and Prevention in collaboration with the 
American Academy of Periodontology (CDC-AAP)29. For a complete overview of the clinical characteristics of 
the cirrhosis patients see Tables 1 and S1.
After the oral examination, the sites to be sampled were selected. The plaque collection procedure was 
preceded by removal of supragingival plaque and the gingival margin was wiped dry with a sterile cotton pellet. 
Subsequently, a curette was inserted into a site of the gingival pocket with a depth of 4 mm or more, and the 
plaque sample was removed by a single curette stroke. The procedure was repeated for another gingival pocket in 
a different quadrant. The two plaque samples from each patient were pooled in 750 µl PowerLyzer™ PowerSoil® 
Bead Solution buffer and stored at −80 °C. An authorised dental hygienist undertook the oral examinations and 
plaque collections. Prior to study start, she was trained by an experienced clinical examiner in periodontitis from 
the Department of Odontology, Aarhus University, Denmark.
DNA extraction. At arrival of the samples to the laboratory at Aarhus University, DNA was immediately 
extracted from the samples using PowerLyzer PowerSoil DNA Isolation Kit (MO-BIO, Carlsbad, CA) and accord-
ing to the manufacturer’s instructions with the exception that a Fastprep FP120 (Qbiogene, Carlsbad, CA) was 
used to release DNA. Briefly, after thawing, 60 µl of the C1-solution were added to the sample and the samples 
were then transferred to a Powerlyser Glass Bead Tube. DNA was released from the cells using a Fastprep FP120 
machine (Qbiogene, Carlsbad, CA) at 5.5 ms−1 for 30 seconds. The treatment was repeated three times and the 
samples were cooled in ice between the treatments. After the bead beating step the user manual was followed 
from paragraph number 7. DNA was eluted in 100 µl C6 buffer supplied from the kit. The extracted DNA was then 
examined for concentration and purity on a NanoDrop 2000 spectrophotometer (Thermo Scientific, Waltham, 
MA) and all samples fulfilled the requirements of GATC-Biotech of a total DNA concentration of 1–50 ng/µl and 
an OD 260/230 >1.8; OD 260/230 >1.9.
PCR amplification and Sequencing. Purified DNA was send to GATC-Biotech (Konstanz, Germany) 
for PCR amplification and sequencing using their internal protocol. Briefly, the V1-V3 region of the 16S 
rRNA gene was amplified using the 27F primer (5′-AGAGTTTGATCCTGGCTCAG-3′) and the 534R primer 
(5′-ATTACCGCGGCTGCTGG-3′) resulting in an amplicon of approximately 508 bp. After initial amplifica-
tion of the V1–V3 region, the PCR products were purified and the tagged adapters were added through fusion 
primer PCR. Preparative gel purification was performed before loading the library on the sequencing machine. 
Due to known problems with the V3 MiSeq chemistry on 2 × 300 bp (see http://blog.Mothur.org/2014/09/11/
Why-such-a-large-distance-matrix/ for discussion of the problems), the samples were sequences with an 
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optimized protocol for 2 × 300 bp paired-end sequencing on the Illumina HiSeq. 2500 sequencing system (San 
Diego, CA, USA). This method has been developed jointly by GACT-Biotech and the Illumina company and has 
been accredited according to ISO17025. DNA extraction controls as well as positive and negative controls for 
PCR reactions were included. Because extraction controls showed no PCR products, they were not included for 
sequencing.
Data processing and analysis of the cirrhosis patient samples. To reduce the error rate of the reads, 
processing of raw reads from the Illumina platform was done using the Mothur software ver. 1.39.1 and following 
the MiSeq SOP (https://www.Mothur.org/wiki/MiSeq_SOP)30 with some modifications. Initially, the paired-end 
reads were combined using the command “make.contig” generating 3–4 million reads per sample. Due to the 
available computer power, the number of reads was then randomly reduced, using the Sub.sample command in 
Mothur, to exactly 1 million reads per sample similar to the number of reads if the samples were sequenced on 
the Illumina MiSeq sequencing platform. The combined reads were then trimmed off the primer sequence and 
sequences containing ambiguous bases or containing longer stretched of homopolymers than eight were dis-
charged from further analysis. The reads were afterwards aligned against the Silva reference alignment ver. 128 
and the resulting alignment was filtered so that all of our reads only overlapped the same region. To further reduce 
the number of sequencing errors, a preclustering step implementing a pseudo-single linkage algorithm originally 
developed by Huse et al.31 with the “diff ” variable set to four was performed. Chimeras were removed using the 
build-in version of the UCHIME algorithm in Mothur32. Lastly, all singletons, duplicates, and triplicates were 
removed before final analysis to preclude inclusion of sequences from potential contamination or sequence errors 
that have not been detected in the previous steps. The resulting reads were then classified with the classify.seqs 
command using the Bayesian method and the taxonomic outline ver. 14.51 from the Human Oral Microbiome 
Database (HOMD) (http://www.homd.org/)33. The confidence cut-off was set to 80%. HOMD is a curated data-
base of known oral bacterial species, and allows one to classify the sequences to species level. All samples were 
then rarefied to 400,000 sequences per sample using the sub.sample command in Mothur and clustered into 
operational taxonomic units (OTU) defined by a 98,5% similarity level using the opticlust clustering method in 
Mothur. The 98.5% similarity level was chosen as many named oral bacterial species have high sequence identity 
Age, years (median, IQR) 62 (59–74)
Female/Male 5/16
Cirrhosis etiology
  Alcohol 15
  Cryptogenic 4
  Autoimmune or cholestastic 2
Cirrhosis severity (median, IQR)
  Child-Pugh score 9 (7–11)
  Model of End-Stage Liver Disease score 13 (8–20)
Smoker status
  Current/Former/Never 10/7/4
Daily alcohol use
  Yes/No 10/11
Charlson comorbidity index
  0 12
  1 7
  2 1
  3+ 1
Medical use at examination
  Lactulose 10
  Pantoprazole 7
  Rifaximin 4
  Antibiotics use within the last ½ year 12
Periodontal measures (median, IQR)
  Number of teeth 24 (16–27)
  Probing depth all teeth, mm 3.11 (2.72–3.85)
  Clinical attachment level all teeth, mm 3.43 (2.83–4.25)
  Bleeding on probing, all sites (%) 50 (14–92)
Periodontitis
  CDC-APP mild cases 2
  CDC-APP moderate cases 8
  CDC-APP severe cases 11
Table 1. Characteristics of the patient cohort (n = 21). IQR, interquartile range.
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in their 16 S rRNA genes, particularly among the streptococci, Actinomyces and Neisseria. Therefore, a number of 
different species are likely to be combined into the same OTU when applying the more commonly used distance 
of 0.03, as previously discussed34. The resulting OTUs were then classified using the classify.otu command in 
Mothur and the HOMD database. The workflow is outlined in Fig. 1.
To identify potential clinical and medical confounding factors that may affect the microbial composition in 
our samples, Principal Coordinates (PCoA) plots based on ThetaYC distances of the OTUs clustered at a 98.5% 
similarity level generated were visualized in R ver. 3.3.2. The factors tested for confounding effect were: Gender, 
smoking, intake of alcohol, diagnosis leading to cirrhosis, severity of periodontitis, use of antibiotics within the 
last six month and lactulose use.
Comparison of our data set with other periodontitis microbiome data sets. To compare our data 
with other microbiome data sets from patients with periodontitis and from healthy controls with no periodon-
titis, we downloaded raw reads from the studies of Griffen et al.35, Abusleme et al.36, and Hong et al.37 from 
the Sequence Read Archive (SRA) at NCBI (SRA accession numbers SRP009299, SRP012422, and SRP038001, 
respectively). The following patient groups were included in the comparison: Periodontitis patients, deep sites, 
periodontitis patients, shallow sites, and healthy controls from the Griffen study, periodontitis patients and 
healthy controls from the Abusleme study, and periodontitis patients from the Hong study. Because of the differ-
ences in amplified 16S rRNA regions and read lengths across studies, all raw sequence reads were reprocessed in 
Mothur v.1.39.5 using the Schloss standard operating procedure (SOP) for 454 pyrosequencing data (http://www.
Mothur.org/wiki/454_SOP)38. After the initial denoising of the data sets with the implemented version of the 
PyroNoise software39 in Mothur. All data sets, including our own data, were then pooled and treated collectively. 
The pooled sequences were first aligned to the Silva reference alignment ver. 128 and the resulting alignment was 
then filtered so that all of our sequences only overlapped the same region. The reads in the resulting alignment 
were, on average, 198 bp. covering the V1 and V2 region of the 16S rRNA gene. To further reduce sequencing 
errors, the preclustering step with the “diff ” variable set to two was performed. Chimeras were removed using 
the UCHIME algorithm. Lastly, all singletons were removed before analysis to preclude inclusion of sequences 
from potential contamination or sequencing errors that had not been detected in the previous steps. All samples 
were rarefied to 4000 sequences per sample prior to downstream analyses using the Sub.sample command in 
Mothur. We choose to rarefy our samples as this method for normalization is still one of the best methods avail-
able especially if the library sizes very considerably (>10x on average) between groups as shown by Weiss et al.40. 
Four thousand reads were chosen as a compromise between keeping most of the samples and keeping most of 
the diversity as shown from the rarefaction curves on Fig. S1. Samples that did not fulfil the minimum number 
of reads were excluded from analysis resulting in 21 cirrhosis samples, 34 periodontitis samples from the Hong 
study, 25 periodontitis samples, deep sites and from the Griffen study, 26 periodontitis samples, shallow sites, 
from the Griffen study, 24 healthy control samples from the Griffen study, 18 periodontitis samples from the 
Abusleme study, and nine healthy control samples from the Abusleme study.
Sequences from all the included data sets including our own data (this time using the 198 bp of the V1–
V2 region) were taxonomically classified using the Bayesian method and the taxonomic outline ver. 14.51 from 
HOMD. The confidence cut-off was set to 80%. Sequences were then clustered into operational taxonomic units 
Figure 1. Flowchart summarizing the processing of the reads from the cirrhosis patients and the comparison 
with reads of downloaded datasets from the Griffen study35, the Hong study37 and the Abusleme study36.
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(OTU) defined by a 98.5% similarity level using the opticlust clustering method. The resulting OTUs were then 
classified using the classify.otu command in Mothur and the HOMD database. Shannon diversity index was 
calculated in Mothur and Student’s t-test was used to detect differences of the Shannon diversity index between 
the groups. Differences were considered significant at p < 0.05. Linear discriminant analysis (LDA) coupled with 
effect size measurement (LEfSe) to detect differentially abundant bacterial taxa (phyla, genera, species) between 
groups. The alpha values for the factorial Kruskal–Wallis and pairwise Wilcoxon tests were set to 0.05 and the 
LDA score threshold for discriminative features was set to 3.5. The online version of the LEfSe program were 
used41 (https://huttenhower.sph.harvard.edu/galaxy/). Principal Coordinates (PCoA) plots based on Unweighted 
Unifrac distances generated from a phylogenetic tree produced in the Clearcut program42 and on ThetaYC dis-
tances of the OTUs clustered at a 98.5% similarity level were vizualised in R ver. 3.3.2. To test if separation of the 
defined groups visualized by the Principal Coordinates (PCoA) plots was statistically significant, a PERMANOVA 
(Permutational Multivariate Analysis of Variance) test was performed using the adonis function in the vegan 
package (version 2.4–4) implemented in R with 999 permutations. Differences were considered significant at 
p < 0.05. The workflow is outlined in Fig. 1 and clinical and sequence characteristics for all samples of the seven 
data sets are shown in Tables 2 and S2.
Availability of data and material. All raw reads were deposited to the NCBI Sequence Read Archive 
(SRA) with the accession number SRP110002.
Ethics approval and consent to participate. The study was performed according to the Declaration of 
Helsinki. The Ethical Committee of Central Denmark Region approved the study (journal No. 1-10-72-128-12). 
Written, informed consent was obtained from all patients included in the study.
Results
Cirrhosis patients. Of the initial 1,000,000 sequences in each sample, the final number of sequences was 
reduced to between 402,937 and 642,319 (mean 577,389) sequences with a mean length of 467 bases after our 
rigorous sequence processing to reduce the numbers of sequence errors. The number of observed OTUs at a 
98.5% sequence similarity ranged from 69 OTUs in sample 6 to 453 OTUs in sample 16 with a mean of 218 OTUs 
(Table 3). The total number of OTUs observed across all samples was 1653 with only 10 OTUs shared between 
all samples. The 25 most abundant OTUs accounted for 52% of all the included sequences. The two most domi-
nant OTUs were classified as Enterococcus durans and Lactobacillus crispatus but both were only found in a few 
samples. However, E. durans (OTU1) comprised more than 96% of all sequences of sample 11, while L. crispatus 
(OTU2) comprised almost 78% of all the sequences of sample 1 (Table S3). The relatively large variation in the 
number of OTUs in the samples was also reflected in the Simpson’s inverse diversity index, which ranged from 
1.62 in sample 1 to 53.54 in sample 8 and with a mean of 17.29 (Table 3). A heatmap generated from the 100 
most abundant OTUs clearly shows that, in most samples, a few OTUs were present in large proportions (>1%) 
(Fig. 2). In addition, when clustering the samples according to the presence of OTUs, no groupings with any clini-
cal or medical parameters were found (Fig. 2). To further investigate whether any differences in the bacterial com-
munity structure between our samples were associated with the clinical or medical characteristics of the included 
patients, we visualised the community structure using a PcoA plot generated from clustering of the sequences at 
98.5% sequence similarity and the ThetaYC calculator (Fig. S2A–F). Although the number of samples in each cat-
egory is small, the differences in the community structure observed between the included patients were probably 
Group
No. 
Samples
No. 
samples 
used for 
analysis
Patient and clinical characteristics Sequence characteristics
Age
Women 
(%)
Probing 
depth, 
all teeth 
(mean, 
mm)
Probing 
depth 
sampled 
sites (mm)
Sequencing 
technology
Variable 
regions 
sequenced
Variable 
regions 
used for 
analysis
Sequence 
alignment 
lenght 
(bp, 
average)
Sequences 
before 
rarefying 
(bp, 
mean)
OTU’s 
(98.5%, 
average)
Good’s 
coverage
Cirrhosis  
patients 21 21
62 
(median) 24 3.2 ≥4 Illumina HiSeq V1–V3 V1–V2 198 678,892 156 0.97
Hong  
periodontitis 34 34 52 (mean) 35.3 3.2 7 454 FLX V1–V2 V1–V2 198 6,263 149 0.98
Griffen 
periodontitis  
deep sites
29 25 54.1 (mean) 34.5 ND 6.2 454 FLX V1–V2 V1–V2 198 5,331 182 0.98
Abusleme 
periodontitis 22 18
42.5 
(mean) 54.5 3 5 454 FLX V1–V2 V1–V2 198 5,839 122 0.99
Griffen 
periodontitis 
shallow sites
29 26 51.3 (mean) 34.5 ND 3.2 454 FLX V1–V2 V1–V2 198 5,371 169 0.98
Griffen  
healthy  
controls
29 24 54.1 (mean) 65.5 ND 2.81 454 FLX V1–V2 V1–V2 198 5,797 115 0.99
Abusleme  
healthy  
controls
10 9 34.1 (mean) 80 1.5 ND 454 FLX V1–V2 V1–V2 198 6,801 64 0.99
Table 2. Clinical and sequence characteristics for all dataset used for comparison.
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not due to differences between subjects in a single parameter alone. However, the diversity of clinical and medical 
characteristics of the samples may increase the overall variation of the community structure as indicated by the 
low number of shared OTUs between all samples.
Taxonomic classification of the sequences using the HOMD database showed that nine different phyla 
were found across all 21 samples with the Firmicutes phylum as the most abundant in most samples; average 
55% (range: 21–98%) of all the sequences (Fig. 3A and Table S4). Of the nine phyla detected, only Firmicutes, 
Bacteroidetes and Actinobacteria were detected in all samples. Interestingly, the phylum Fusobacteria, which is 
a normal colonizer of the oral cavity43, was absent from two samples and found in low relative numbers (<1%) 
in eight other samples. Similarly, Spirochaetes were also absent from two samples and found in very low pro-
portions (<0.1%) in eight other samples. At a lower taxonomic level, 80 named genera were detected compris-
ing 97% of the total sequences included in the study (Table S4). Furthermore, 26 unnamed genera were found 
especially in the Lachnospiraceae family and in the Peptostreptococcaceae family (Table S4). Of the sequences, 
0.3% were not assigned to genus level. Streptococcus, Lactobacillus, Actinomyces, Prevotella, and Cutibacterium 
(Propionibacterium) were the only genera found in all samples. The low number of genera shared is most likely 
explained by very high proportions of the genera Lactobacillus and Enterococcus in samples 1 and 11, respectively 
(Fig. 3B and Table S4). The number of named genera in each sample ranged from 21 genera in sample 6 to 54 in 
samples 5 and 16 (average 38 genera), but in most of the samples only a few genera were found in relatively high 
proportions (>1%) (Fig. 3B).
A total of 181 formally described species were detected (corresponding to 75% of all sequences), while 139 
undescribed species or taxa classified as an “oral taxon” belonging to a specific named genus in the HOMD were 
found (corresponding to 14% of all sequences) (Table S4). Most of the undescribed oral taxa belonged to the 
Actinomyces (12), Prevotella (15), Capnocytophaga (8), Selenomonas (12), and Treponema (8) genera. Eleven % of 
the sequences could not be assigned to species level with HOMD.
The number of named species and unnamed oral taxa found in each sample ranged from 33 in sample 1 
to 205 in sample 16 (mean = 113). The three most abundant species were Enterococcus durans, Lactobacillus 
crispatus, and Veillonella parvula. However, only the latter was found in most samples and only Cutibacterium 
(Propionibacterium) acnes and Campylobacter gracilis were found in all samples (Table S4). While Campylobacter 
gracilis was relatively abundant in several samples, C. acnes was found only in minor proportions in most samples. 
The three members of the red complex (Porhyromonas ginigivalis, Tannerella forsythia, Treponema denticola), a 
group of bacteria significantly associated with severe periodontal disease44 were found in very low proportions 
in most samples, with the exception of sample 16 where species from the red complex accounted for nearly 10% 
of the total community (Fig. 4A). However, if one of the species was found in larger proportions (>1%), at least 
two of the species belonging to the red complex were always detected. Bacteria belonging to the orange complex44 
(Fusobacterium nucleatum (subspecies polymorphum, subspecies nucleatum, subspecies vincentii), Fusobacterium 
periodonticum, Prevotella intermedia, Prevotella nigrescens, Parvimonas micra (formerly Peptostreptococcus 
micros), Streptococcus constellatus, Eubacterium nodatum, Campylobacter showae, Campylobacter gracilis, 
Campylobacter rectus) were more abundant in most samples and accounted, in total, for an average of 12.8% 
(range: 0.0002–39.2%) of the individual microbial communities (Fig. 4B). Three of the orange complex species 
Sample
No. of 
sequences
Good’s 
coverage
OTUs 
(98.5%)
invsimpson 
diversity index
npshannon 
diversity index
1 622,881 1.00000 93 1.6 1.0
2 605,126 1.00000 256 11.4 3.2
3 402,937 1.00000 71 3.5 1.7
4 578,223 1.00000 218 27.7 3.8
5 626,181 1.00000 323 14.4 3.7
6 594,296 0.99999 69 8.8 2.5
7 490,496 0.99999 123 6.0 2.1
8 538,865 0.99999 402 53.5 4.6
9 580,848 0.99999 171 15.9 3.3
10 626,790 0.99999 122 14.5 3.0
11 628,812 1.00000 130 1.1 0.3
12 642,319 0.99999 112 3.8 1.7
13 638,673 1.00000 181 4.9 2.7
14 542,274 0.99999 299 48.7 4.3
15 586,535 1.00000 402 36.6 4.3
16 555,276 0.99999 453 48.3 4.6
17 612,666 0.99999 252 7.6 2.9
18 633,027 0.99999 216 7.8 2.9
19 479,118 1.00000 142 8.5 2.6
20 591,593 0.99999 270 14.8 3.4
21 548,228 0.99999 277 23.6 3.7
Table 3. Sample characteristics after reduction of sequencing errors.
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(C. rectus, C. showae, and F. periodonticum) were not found in any of the samples. Interestingly, when species 
belonging to the orange complex accounted for less than 5% of the total population, as in seven of the sam-
ples, species belonging to the red complex were completely absent. While there was no association between the 
Antibiotics
Lactulose
Rifaximin
Pantoprazole
Alcohol
Smoker
Periodontitis
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Figure 2. Heatmap of the relative abundances for the top 100 OTUs found in the subgingival microbial 
communities of the patients with periodontitis and liver cirrhosis. Patients are shown in rows, while OTUs 
appear in columns. Color scale for the heatmap is shown in the top left with the most abundant OTUs in red 
and the least abundant in white. Patients are organized according to results of hierarchical clustering (complete 
linkage) of microbial communities based on OTU relative abundances. Color bars in the left depict the medical 
and clinical characteristics for each patient. Color scales for metadata appear at the bottom.
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presence of the bacteria in the orange complex and the severity of periodontitis of our subjects, the bacteria in 
the red complex were, with one exception, only found in higher proportions (>1%) in subjects with severe peri-
odontitis (Fig. 4A and B).
Comparison of all data sets. We compared our data set with data sets from three other studies to investi-
gate whether the subgingival microbial composition of the subjects with periodontitis and cirrhosis was different 
from that of other patients with periodontitis or healthy controls with no signs of periodontitis. As a consequence 
of the inclusion of other datasets, we had to reduce our own datasets to just 4000 reads per sample and with an 
Figure 3. Cumulative abundance of bacterial taxa at the phylum (A) and genus (B) level for each patient. Only 
the 20 most abundant genera are shown.
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average read length of 198 bp (see methods section for detailed description). The composition of the microbial 
community at the phylum level is comparable using our original dataset and the reduced dataset indicating that 
our findings were robust (Fig. S3). However, the average number of OTUs was reduced from 218 in the original 
dataset to 163 in the dataset rarefied to 4000 reads. The OTU level of our samples was comparable to that of perio-
dontitis cases from all three published studies, while the mean number of OTUs from healthy samples from both 
of the previous studies was significantly lower (t-test, p < 0.01) than that of our dataset (Fig. S4A). In contrast, 
the NPShannon diversity index was comparable for our dataset and the datasets from healthy controls of the 
Abusleme and Griffen studies, while it was significantly lower (p < 0.01) than found for periodontitis patients 
from all three included studies (Fig. S4B).
We compared the beta-diversity of the datasets by generating PCoA plots of the unweighted UniFrac distances 
of the phylogenetic tree generated from the Clearcut program and the ThetaYC distances of the OTUs clustered 
at a 98.5% similarity level. From Fig. 5A and B it is clearly evident that our samples had a different community 
structure from that of the other included datasets of periodontitis patients. Similarly, datasets from the healthy 
controls of the Abusleme study and the Griffen study were clearly distinct from our dataset as well as from the 
datasets from periodontitis patients (Fig. 5A and B). On the other hand, all four datasets from patients with 
periodontitis were not clearly separated from each other by both PCoA plots. The separation observed by both 
PCoA plots was supported by PERMANOVA analysis with p-values below 0.001 between our cirrhosis patients 
and all the other datasets. PERMANOVA revealed borderline significant differences between the datasets from 
periodontitis patients with p-values between 0.05–0.06 except between the datasets of deep sites and shallow sites 
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of the Griffen study where p-values from the PERMANOVA analysis were non-significant (p-values between 
0.2 and 0.3). Although the PERMANOVA analysis revealed borderline significance between the downloaded 
periodontitis datasets, they were pooled to detect potential taxonomic differences between our samples and the 
periodontitis samples. The same was done for the two datasets from healthy controls.
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Figure 5. PCoA plots comparing the subgingival plaque bacterial communities from our patients with liver cirrhosis 
and periodontitis with periodontitis patients and healthy controls from the studies of Hong et al.37, Griffen et al.35, 
and Abusleme et al.36. The percentage of variation explained by each principal coordinate (PC) is indicated on the 
axes. Each point represents a microbial community. The plots are based on the OTU structure (ThetaYC calculator) 
using 98.5% sequence similarity for clustering (A) and on Unweighted UniFrac distances from the phylogenetic tree 
generated from the Clearcut program implemented in the Mothur software (B). Samples from our liver cirrhosis 
patients are shown in green, healthy control samples from the Abusleme study are shown in orange, periodontitis 
patients from the Abusleme are shown in purple, periodontitis samples from the Hong study are shown blue, 
periodontitis samples from deep sites from the Griffen study are shown in red, periodontitis samples from shallow 
sites from the Griffen study are shown in black, and healthy control samples from the Griffen study are shown in grey.
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Taxonomic classification of the sequences from the compared datasets showed a remarkably different micro-
bial composition between our samples and the three datasets from patient with periodontitis at the phylum level 
(Fig. 6A). Clearly, Firmicutes was more abundant in our samples than in all other datasets, while Spirochaetes, 
Fusobacteria, and Bacteroidetes were less abundant than in all the published datasets generated from patients with 
periodontitis. These three phyla were also less abundant in the healthy controls of the Abusleme study and the 
Griffen study when compared to the patients with periodontitis from the same studies (Fig. 6A). Using linear dis-
criminant analysis (LDA) coupled with effect size measurement (LEfSe) to detect differentially abundant bacterial 
taxa (phyla, genera, species), the same differences at the phylum level were confirmed in addition to TM7 and 
Synergistetes being more abundant in periodontitis patients (Fig. 6B). Such major differences at the highest taxo-
nomic level clearly indicate that the two groups have a completely different bacterial community structure, which 
is supported also by the high number of differentially abundant taxa at a lower level between the two groups 
(Figs 6B and S5A). In contrast, only Firmicutes (cirrhosis patients) and Proteobacteria (healthy controls) were 
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Figure 6. Relative abundance with standard deviation of the most abundant phyla detected in the groups after 
collectively processing of the reads from the present study and the studies of Hong37, Griffen35 and Abusleme36 
(A) and differentially abundant bacterial phyla and genera identified by linear discriminant analysis (LDA) 
coupled with effect size measurements (LEfSe) between our samples and the pooled samples with periodontitis 
(B) and the pooled healthy control samples (C) from the three included studies. Only taxa that met the 
significant linear discriminant analysis threshold of 3.5 are shown. Phyla are written in bold.
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differentially abundant at the phylum level between cirrhosis patients and healthy controls (Fig. 6C). Interestingly, 
the species belonging to the red complex, T. forshytia, T. denticola and P. gingivalis, were found to be significantly 
more abundant in periodontitis patients than in our cirrhosis patients with periodontitis but not in samples 
from healthy controls (Fig. S5A and B). In addition, the orange-complex species F. nucleatum, P. intermedia, P. 
nigrescens, and C. rectus were also more abundant in patients with periodontitis than in the cirrhosis patients, 
while S. constellatus (cirrhosis), F. nucleatum subsp. polymorhum (healthy controls) and, C. showae (healthy con-
trols) were found in different abundancies in cirrhosis patients and healthy controls (Fig. S5A and B). Due to rel-
atively short sequences included in these analyses, comparison at the species can be problematic. However, most 
of the genera to which the species in the red and orange complex belong (Treponema, Tannerella, Porphyromonas, 
Fusobacterium, Prevotella, Eubacterium), were also more abundant in periodontitis patients than in cirrhosis 
patients with periodontitis while Fusobacterium and Porphyromonas were actually more abundant in healthy 
controls than in cirrhosis patients (Figs 6B,C and S6).
Discussion
This is the first report on the subgingival microbiome of liver cirrhosis patients suffering from periodontitis. We 
used the 2 × 300 bp V3 Miseq Illumina kit for sequencing of the V1-V3 region of the 16S rRNA gene. While the 
long reads, theoretically, result in a better taxonomic resolution, the method has been criticised for generating 
sequencing errors leading to too many unique reads and, ultimately, an overestimation of the number of OTUs 
present in the samples45 (see this blog http://blog.Mothur.org/2014/09/11/Why-such-a-large-distance-matrix/ for 
a discussion of the problem). To deal with these problems, our sequence provider developed an in-house protocol 
for sequencing of 2 × 300 bp on the HiSeq. 2000 instrument. Together with our rigorous processing of the reads, 
we consider that the error rate in our final reads used for downstream analysis was reduced to a minimum. This 
is supported by the number of OTUs and diversity indexes found in our samples, which were in agreement with 
previous studies of the subgingival plaque microbiome in periodontitis and gingivitis patients using a 98.5% 
16S rRNA gene sequence identity to define OTUs34,46. Although different sequencing methods theoretically may 
affect the outcome of microbiome studies, previous studies have shown that 454 pyrosequencing and Illumina 
sequencing result in only minor insignificant taxonomic differences47,48. Therefore, we trust our data and consider 
our findings to be valid.
Our patients suffered from liver cirrhosis mainly due to present or former alcohol abuse. However, they were 
very diverse in many other clinical and medical parameters that might affect the composition of the subgingival 
microbiome. We did not find that the plaque microbiome was affected by a single clinical or medical factor but 
was more likely affected by several concurrent factors. More than half of our patients had received antibiotics 
(including rifaximin) within half a year before the sampling, and many of the patients had received antibiotics 
close to the sampling. Antimicrobial therapy may be the single factor that affects the microbiome most on both 
a short-term and long-term scale49. However, a study by Zaura et al.50, in which the authors studied the changes 
in the faecal and salivary microbiome due to antibiotics in 66 healthy adults, revealed a profound and long-term 
change in the faecal microbiome, while the salivary microbiome was more resilient and not considerably affected. 
This is in accordance with the absence of a specific alteration of the composition of the microbiome or a reduction 
in the number of observed OTUs in our patients receiving antibiotics prior to the sampling.
The mean age of patients examined in this study was somewhat higher than in most studies of periodontal 
disease etiology, but although the oral microbial community changes during the lifetime, the most significant 
age-related changes take place during childhood and adolescence and only minor changes are seen during adult-
hood51. General dental hygiene affects the composition of the oral microbiome and poor dental hygiene favors a 
microbial community as associated with periodontitis. However, the dental hygiene observed in our patients was 
not different from that previously reported for periodontitis patients.
Another factor that might disturb the microbiome in liver cirrhosis patients is lactulose, which is used as a 
prebiotic for patients with liver cirrhosis and hepatic encephalopathy52–54. Lactulose acidifies the colonic pH, 
which renders the environment hostile to the urease-producing Klebsiella and Proteus species, while promoting 
non-urease-producing and aciduric lactobacilli and bifidobacteria55. In the few studies that have investigated 
the direct effect of lactulose on the gut microbiome in liver cirrhosis patients no major changes of the gut micro-
biome composition were found56,57. Interestingly, however, Lactobacillus species were very abundant in several 
of our patients accounting for more than 19% (19–89%) in six of our samples, of which four had received lac-
tulose, suggesting that lactulose may increase the oral abundancy of this genus in patients with liver cirrhosis. 
Lactobacillus has not been found to be abundant in the oral cavity of otherwise healthy periodontitis patients 
or controls43,58,59, but is generally considered to have a beneficial role in periodontal diseases by suppressing the 
growth of periodontal pathogens by its antimicrobial and anti-inflammatory properties5,60. This might explain the 
low abundances of species from the red and orange complexes in samples rich in Lactobacillus species. However, 
a recent study61 found that Lactobacillus gasseri was highly abundant in periodontitis patients and especially 
in progressing periodontitis patients but not in healthy controls. If confirmed, these findings suggest different 
properties of Lactobacillus species or even clones of the same species62 and do not exclude that lactobacilli are 
involved in periodontitis development in specific patients like liver cirrhosis patients when other more common 
periodontal pathogens are suppressed.
In spite of individual differences, the subgingival microbiome in periodontitis patients is distinct from that 
of healthy people43,58,59. Several studies have found that phyla like Bacteroidetes, Spirochaetes, and Fusobacteria 
are more abundant in patients with periodontitis35,36,63. Interestingly, we did not find high proportions of these 
phyla in the subgingival microbiota associated with periodontal attachment loss in cirrhotic patients. Our sam-
ples were dominated by Firmicutes and to a lesser extend Actinobacteria, both of which have been associated 
with health58,63. This conclusion is supported by comparison of our data with those of three other studies, which 
showed that the composition of our samples was more similar to the included healthy control samples at the 
www.nature.com/scientificreports/
13SCientiFiC REPORTs |  (2018) 8:10718  | DOI:10.1038/s41598-018-28905-w
phylum level. Synergistetes and TM7 were almost absent from our samples, and both phyla have been suggested 
to be associated with periodontitis64,65. The absence of these phyla could be a methodological issue, as proposed 
by Griffen et al.35, who observed a lower detection rate of these two phyla when using the V1 regions of the 16 S 
rRNA gene compared to the V4 region for taxonomic assignment. However, we find it more likely that the two 
phyla were truly absent from our samples in accordance with the conclusion supported by the PCoA analysis that 
the microbial compositions of our samples are more similar to that found in healthy subjects.
Theoretically, the pocket depth of the sampling sites might explain the differences in the microbial communities 
between our patients with liver cirrhosis and patients from the compared data sets. While the PD and CAL from 
all teeth of the patients were comparable between our patients and the comparison studies, the PD at the sampling 
sites varied between the studies. However, Griffen et al.35 showed that the abundance of disease-associated bacterial 
species was almost similar between shallow sites (mean PD 3.2 mm) and deep sites (mean PD 6.2 mm) from the 
same patients, which was also confirmed by our analysis. Similarly, Hong et al.37 found that a higher mean overall 
PD was a better prediction parameter for periodontal disease-associated bacteria than the PD at sampling sites. In 
conclusion, these findings suggest that overall periodontal status of the patient more accurately reflects the subgin-
gival plaque community than the PD/CAL at the actual sampling site. In conclusion, we acknowledge that both 
sampling, sequencing, and clinical differences of the included patients from the compared datasets may impact the 
microbiological findings. However, it is conceivable that such differences are relatively minor and that the observed 
differences in the bacterial composition between our patients and the included datasets are real and associated with 
the liver cirrhosis and ensuing immune dysfunction in our patients.
It is well established that liver cirrhosis patients become immunocompromised, which is responsible for many 
of the complications observed, including bacterial infections66,67. The changes in the gut microbiota in liver cir-
rhosis patients have been proposed to be caused by a combination of the direct effect of the liver on the gut 
as well as by their immunocompromised status22,24,55. Recent studies showed that the oral microbiome associ-
ated with periodontitis differs greatly between HIV positive and HIV negative patients46,68,69. In the study by 
Noguera-Julian et al.68 Neisseria species were enriched in HIV-positive patients. Interestingly, genera belonging 
to the red complex (Tannerella, Treponema, Porhyromonas)44 were found in low amounts in both HIV-positive 
and HIV-negative patients. However, in two other studies by Kistler et al.46 and Goldberg et al.70 no overall dif-
ferences in the oral bacterial community structure was found between well-controlled HIV-positive children and 
HIV-negative children as well as HIV-positive adults undergoing highly active antiretroviral therapy (HAART) 
and HIV-negative adults, respectively. These studies clearly demonstrate that the immune status of the liver cir-
rhosis patients may alter the bacterial community, in accordance with what we observed in the oral cavity.
Complete appreciation of the causal relationship between liver cirrhosis and periodontal disease requires 
information on the exact time of debut of the two diseases. As both diseases are characterized by slow progression 
and may be influencing the immune system long before a clinical diagnosis is made, it would be almost impos-
sible to determine the order of the two diseases. On the other hand, it has been shown that periodontal diseases 
are more prevalent in patients with liver cirrhosis patients than in similar patient groups without liver cirrhosis71, 
which suggests a causal relationship between liver cirrhosis and periodontal diseases.
Periodontal disease is a result of dysbiosis, which in most patients is caused by an increased microbial chal-
lenge due to various factors associated with modern life-style5,72. However, dysbiosis may also be the result of 
reduced host resistance to the microbial challenge. It is conceivable that the observed periodontal microbiota in 
cirrhotic patients, which is compatible with periodontal heath in healthy individuals, is capable of causing inflam-
mation and attachment loss when affected only by a compromised immune defense.
An increasing body of literature links the oral microbiome with diseases in other parts of the human body10. 
Studies of the gut microbiome in patients with liver cirrhosis show an increased abundance of some genera of oral 
origin like Veillonella, Prevotella, Neisseria, and Haemophilus, and suggest that salivary dysbiosis in these patients 
may be linked to an oral pro-inflammatory environment, systemic inflammation, and constitute a risk for sub-
sequent liver-related hospitalization24,27. Interestingly, Aberg and Helenius-Hietala73 proposed that periodontitis 
may be of special interest in liver cirrhosis patients for the translocation of oral bacteria to the gut and for the risk 
of subsequent liver-related hospitalization. This may be due to the release of periodontal bacteria and their toxins 
into the circulation during periodontitis14. Reports have shown that dental diseases accelerated the progression of 
liver disease and the overall mortality in liver cirrhosis patients74,75.
In this study, we found that that the subgingival plaque microbiome in patients with liver cirrhosis and perio-
dontitis differed from that of otherwise healthy patients with periodontitis. Especially, bacterial species normally 
associated with periodontitis from the red complex and to a lesser extend from the orange complex were less 
abundant in our samples. We hypothesize that periodontitis in patients with liver cirrhosis is associated with 
bacteria normally compatible with health due to the dysbiotic situation caused by the immunocompromised 
status of most liver cirrhosis patients. Our findings emphasize that dysbiosis leading to periodontal disease may 
be due either to changes in the composition of the microbiota or to changes of the host’s immune responses or to 
both. Our study strengthens the connection between liver cirrhosis and oral health. Liver cirrhosis patients often 
develop oral diseases like periodontitis and oral diseases in liver cirrhosis patients may aggravate their prognosis. 
Therefore, it is vital to follow the oral health of liver cirrhosis patients, and further studies have to be conducted to 
establish the role of the oral microbiome in the pathogenesis of liver cirrhosis.
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